Navigation Links
Sixth Generation Elekta Digital Control System Boosts Radiation Therapy System Speed and Performance
Date:2/10/2012

ATLANTA, Feb. 10, 2012 /PRNewswire/ -- The advanced functionality of Elekta's family of digital linear accelerators demands the highest degree of intelligent coordination. Elekta's latest control system, Integrity™ R1.1, meets this requirement through three tiers of safety, command of MLC interdigitation for exceptional field shaping, and support of virtually limitless options to adjust the radiation dose.

Integrity R1.1 has undergone rigorous tests in eight international centers, which demonstrated safe reductions in treatment delivery times of as high as 30 percent. The receipt of 510(k) clearance for Integrity R1.1 enables U.S. medical centers to realize these treatment speed and safety benefits when Elekta begins delivery of the control systems.

"I appreciate the use of multiple measures to ensure correct treatment delivery," says Jonas Fontenot, Ph.D., physicist at Mary Bird Perkins Cancer Center (Baton Rouge, La.), which has been evaluating a previous release of Integrity since February 2011. "In addition, during Volumetric Modulated Radiation Therapy [VMAT], Integrity constantly captures delivery parameters and sends them back to our MOSAIQ® oncology information system, where they become part of the patient's electronic record."

Interdigitation and Continuously Variable Dose Rate (CVDR) boost efficiency

With interdigitation of MLCi2 enabled by Integrity R1.1, MLC capabilities have caught up with the ability of the treatment planning system to create fields with complex geometry. Because MLC leaves can move past one another – or interdigitate – clinicians can employ island fields in difficult cases, such as those involving multiple targets.

"Interdigitation is important for treating multiple targets – such as multiple brain mets – and also when there is a target geometry that consis
'/>"/>

SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Bacterin to Present at Sixth Annual Singular Research Best of the Uncovereds Conference on October 26, 2011
2. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
3. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
4. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
5. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
6. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
7. Premier Awards Sixth Consecutive Contract to Instrumentation Laboratory for Critical Care Portfolio
8. AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing
9. Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance
10. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
11. Statement of Ben Anderson, Esq., Regarding Denial of Wyeths En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Decision Resources, one of the world,s leading ... that, over the past 12 months, 25 percent of surveyed ... Germany , Italy , ... ) have been required to change the antiretroviral (ARV) ... to reduce costs. Additionally, more than 40 percent of respondents ...
(Date:6/18/2013)... June 18, 2013 Today, Wall Street ... GILD ), Health Management Associates Inc. (NYSE: ... ), ISIS Pharmaceuticals Inc. (NASDAQ: ISIS ), and ... reports free of charge - including full price targets, industry ... Gilead Sciences, Inc. Research Report On June ...
(Date:6/18/2013)... , June 18, 2013 Apama ... on the development of next-generation atrial fibrillation technologies, ... 8295902 by the US Patent and Trademark Office ... low profile electrode assemblies for use on expandable ... or other surgical procedures. "We are ...
Breaking Medicine Technology:One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 2One in Four Surveyed EU5 Physicians Has Been Required to Change a Prescription for Some or Most of Their HIV Patients in the Past Twelve Months, Primarily to Reduce Costs 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6
... 2011 Data presented at the 47th American Society ... of circulating tumor cells (CTC) as a biomarker for ... first randomized, double-blind, placebo controlled Phase III trial to ...  Biomarkers are of scientific interest as, if validated, they ...
... 3, 2011 Civil penalties amounting to $327,073,700 have ... South Carolina versus Ortho-McNeil-Janssen Pharmaceuticals and Johnson & Johnson, ... on June 3 through a written order. John B. ... White, Smith & Coggins, P.C., a Spartanburg-based law firm, ...
Cached Medicine Technology:Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials 2Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials 3Late-Breaking ASCO Data Demonstrate Circulating Tumor Cells as Potential Biomarker for Metastatic Prostate Cancer Clinical Trials 4Record Breaking $327 Million Verdict Announced in Janssen Case 2
(Date:6/18/2013)... Tarrytown, NY (PRWEB) June 18, 2013 ... simply to grow in size. Quite the opposite. ... and audiology practice-with over 140 expertly trained physicians offering ... communities in 40 locations throughout the Greater New York ... the important circumstances are right. And that includes the ...
(Date:6/18/2013)... (PRWEB) June 18, 2013 Sun Buick GMC, ... Family Health Services 20th Annual Golf Tournament on Thursday, June ... The hole-in-one prize is a 2013 Buick Verano and will ... gets a hole-in-one on Irem’s 7th hole. , The MFHS ... format is a four person captain and crew team for ...
(Date:6/18/2013)... have a much different and more complex ... of Texas at Dallas have found that exploiting these ... cancer. , In an article published online May 21 ... researchers compared the metabolic characteristics of non-small-cell lung cancer ... patient. , They found that the cancer cells ...
(Date:6/18/2013)... HOUSTON Researchers have discovered and mapped the signaling ... that, if broken, could cut off cancer cell growth ... scientists at The University of Texas MD Anderson Cancer ... (EGFR), a well-known cancer drug target, and MCM7, a ... in the June issue of Cancer Cell . ...
(Date:6/18/2013)... 2013 The Elizabeth Glaser Pediatric AIDS ... the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) ... new milestones in the global effort to eliminate pediatric ... that as of June 2013, one million babies globally ... Since PEPFAR’s inception in 2003, EGPAF has been a ...
Breaking Medicine News(10 mins):Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 2Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 3Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 4Health News:ENT and Allergy Associates Merges with Hudson Valley ENT, Adds Five Superb Physicians, Expands Overall County Presence 5Health News:UT Dallas study suggests new approach to fight lung cancer 2Health News:UT Dallas study suggests new approach to fight lung cancer 3Health News:Scientists catch EGFR passing a crucial message to cancer-promoting protein 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 2Health News:One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS 3
... anti-TNF agents (etanercept) and chemotherapy drug methotrexate has ... of Rheumatoid Arthritis.// Furthermore, the progression of joint ... three quarters of patients. The chronic nature of ... prevention of long-term joint damage in addition to ...
... out of a roller coaster ride could be sufficient enough ... leading to potential life threatening complications including heart attack.// ... people (37 men and 18 women) who volunteered to take ... a slow rise to 62 metres above the ground, followed ...
... improve exercise capacity and functional ability in patients with ... in the blood vessels that enter the lungs, a ... Reuters, the findings, which appear in The New England ... 278 patients who were randomly selected to receive Viagra, ...
... only to South Africa with respect to the number of ... AIDS in India has revealed that the figures could be ... been numerous repots claiming a dramatic decline in the number ... following the release of the U.N. annual global report on ...
... Journal of the National Cancer Institute conducted a meta-analysis ... diabetes and the prevalence and associated mortality from colorectal ... M.Sc., of the Karolinska Institute in Stockholm, and colleagues. ... were at a 30 percent risk of developing colorectal ...
... Lung Association suggests that Canadians know little about COPD, a ... in the country. //, ,The study graded all the ... In a provincial report card delivered by the association, most ... to public and physician awareness, access to testing and treating ...
Cached Medicine News:Health News:Combination Therapy With ENBREL And Methotrexate Found Effective In RA Treatment 2Health News:AIDS Picture In India Not As Rosy As It Seems To Be 2Health News:Canadians Oblivious About COPD, A Debilitating Lung Disease 2
... Seat height: Bench high, 26-31". Ergonomic ... "Soft Touch" pnuematic control for easy ... Static-control casters allow easy mobility. Fixed ... Decay (from 5000 Volts to technical ...
Attachments: Clip bar for tubes 10 to 19 mm in diameter Overall Dimension Height IC: 6 (15.2) Overall Dimension Length IC: 18.5 (46.9) Overall Dimension Width IC: 4 (10.2)...
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
The model 55D Rocking Shaker provides the same Reliable quality as the 55S, but double the value. The 55D gives you an additional platform with a height of 3.25 in....
Medicine Products: